Gao JJ, Osgood CL, Gong Y, Zhang H, et al. FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf injection for subcutaneous use in Patients with HER2-Positive Breast Cancer. Clin Cancer Res 2020 Nov 13. pii: 1078-0432.CCR-20-3474.
PMID: 33188141